logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Sectors
QNTM
Quantum BioPharma Ltd.
3.17
1 x 3.17
1 x 3.21
bid
ask
+
0.09
3.09%
1 @ 05:34 PM
3.27 +0.10 (3.10%)
Ytd-56.58%
1y-81.19%
3.02
day range
3.23
2.07
52 week range
21.00
Open3.02Prev Close3.08Low3.02High3.23Mkt Cap20.38M
Vol80.67KAvg Vol219.38KEPS-4.49P/EN/AForward P/E-0.41
Beta0.45Short Ratio0.09Inst. Own16.65%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1850-d Avg3.33200-d Avg5.021yr Est169.00

QNTM News

12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

Gainers Lakewood-Amedex (NASDAQ:LABT) stock rose 38.0% to $3.45 during Monday's after-market se
benzinga.com
Rodman & Renshaw Initiates Coverage On Quantum BioPharma with Buy Rating, Announces Price Target of

Rodman & Renshaw analyst Michael King initiates coverage on Quantum BioPharma (NASDAQ:QNTM) w

Quantum Biopharma Provides Corporate Update
globenewswire.com
Quantum Biopharma Provides Corporate Update

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION T

12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session

Gainers INVO Fertility (NASDAQ:IVF) shares increased by 163.4% to $2.56 during Monday's pre-mar

Quantum BioPharma Strengthens Equity and Liquidity in Q2 2026 as FDA Approves Lucid-MS for Pivotal Phase 2 Clinical Trial
globenewswire.com
Quantum BioPharma Strengthens Equity and Liquidity in Q2 2026 as FDA Approves Lucid-MS for Pivotal P

TORONTO, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0

Quantum BioPharma Receives United States FDA Clearance To Proceed with Lucid-MS Phase 2 Trial in Progressive Multiple Sclerosis:
globenewswire.com
Quantum BioPharma Receives United States FDA Clearance To Proceed with Lucid-MS Phase 2 Trial in Pro

Major Regulatory Milestone Positions Company to Initiate Randomized, Double-Blind, Placebo-Controlle

EXCLUSIVE: Quantum BioPharma Achieves Major Milestone With FDA Clearance for Multiple Sclerosis Trial
benzinga.com
EXCLUSIVE: Quantum BioPharma Achieves Major Milestone With FDA Clearance for Multiple Sclerosis Tria

FDA approves Quantum BioPharma's IND application for Lucid-MS, advancing its progressive multipl

Quantum Biopharma (QNTM) Projected to Post Quarterly Earnings on Thursday
defenseworld.net
Quantum Biopharma (QNTM) Projected to Post Quarterly Earnings on Thursday

Quantum Biopharma (NASDAQ: QNTM - Get Free Report) is anticipated to announce its results before the

Quantum BioPharma Announces Closing of Debt Settlement
globenewswire.com
Quantum BioPharma Announces Closing of Debt Settlement

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION T

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Gainers Jupiter Neurosciences (NASDAQ:JUNS) stock rose 36.4% to $0.23 during Tuesday's pre-mark

Quantum BioPharma Announces Intention to Settle Debt
globenewswire.com
Quantum BioPharma Announces Intention to Settle Debt

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION T

Quantum BioPharma Provides Corporate Update
globenewswire.com
Quantum BioPharma Provides Corporate Update

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION T

NetworkNewsAudio Announces Audio Press Release (APR) the Advancement of First-in-Class Treatment for Multiple Sclerosis
globenewswire.com
NetworkNewsAudio Announces Audio Press Release (APR) the Advancement of First-in-Class Treatment for

AUSTIN, Texas, June 26, 2026 (GLOBE NEWSWIRE) -- via IBN – NetworkNewsAudio announces the Audio Pres

Quantum BioPharma Ltd. (NASDAQ: QNTM) Advancing Innovative, First-in-Class, Patented MS Therapy
globenewswire.com
Quantum BioPharma Ltd. (NASDAQ: QNTM) Advancing Innovative, First-in-Class, Patented MS Therapy

NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Quantum BioPharma Ltd. (NASDAQ: QNTM) (

Quantum BioPharma Ltd. (NASDAQ: QNTM) Developing Patented, First-in-Class MS Treatment That Offers Different Approach
globenewswire.com
Quantum BioPharma Ltd. (NASDAQ: QNTM) Developing Patented, First-in-Class MS Treatment That Offers D

NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- via BioMedWire — Quantum BioPharma Ltd. (NASDAQ: QNTM) (

IBN Announces Latest Episode of The BioMedWire Podcast Featuring Anthony Durkacz, Executive Co-Chair of Quantum BioPharma Ltd.
globenewswire.com
IBN Announces Latest Episode of The BioMedWire Podcast Featuring Anthony Durkacz, Executive Co-Chair

Disseminated on behalf of  Quantum BioPharma , may include paid advertisements. AUSTIN, Texas, June

Quantum BioPharma Engages Stocks.news For Investor Relations, Marketing Services And Lead Generation Campaigns
globenewswire.com
Quantum BioPharma Engages Stocks.news For Investor Relations, Marketing Services And Lead Generation

TORONTO, June 02, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0

Quantum BioPharma Provides Corporate Update
globenewswire.com
Quantum BioPharma Provides Corporate Update

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION T

12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's After-Market Session

Quantum BioPharma Momentum Score Surges As Investors Cheer Progress In MS Research
feeds.benzinga.com
Quantum BioPharma Momentum Score Surges As Investors Cheer Progress In MS Research

Quantum BioPharma stock momentum surges as MS study hits 50% enrollment and early PET imaging data s

Quantum BioPharma Momentum Score Surges As Investors Cheer Progress In MS Research
benzinga.com
Quantum BioPharma Momentum Score Surges As Investors Cheer Progress In MS Research

Quantum BioPharma stock momentum surges as MS study hits 50% enrollment and early PET imaging data s

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session

12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Pre-Market Session

Quantum BioPharma Reaches Key Midpoint Milestone in Groundbreaking Imaging Study with Massachusetts General Hospital
globenewswire.com
Quantum BioPharma Reaches Key Midpoint Milestone in Groundbreaking Imaging Study with Massachusetts

TORONTO, May 18, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K

Quantum Reports Strengthened Liquidity, Reduced Cash Burn, and Disciplined Cost Management in First Quarter 2026
globenewswire.com
Quantum Reports Strengthened Liquidity, Reduced Cash Burn, and Disciplined Cost Management in First

TORONTO, May 07, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K

Quantum BioPharma Provides Corporate Update
globenewswire.com
Quantum BioPharma Provides Corporate Update

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION T

Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwide Commercialization of Innovative, Clinically Validated Hangover Remedy and Alcohol Metabolism Accelerant
globenewswire.com
Quantum BioPharma Licensee Unbuzzd Wellness Inc. Appoints Richard Buzbuzian as CEO to Lead Nationwid

TORONTO, April 22, 2026 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA:

benzinga.com
Quantum BioPharma Announces U.S. District Court For The Southern District Of New York Rules Against

Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) (FRA: 0K91) ("Quantum BioPharma" or the &#34
benzinga.com
Quantum BioPharma Submits IND Application To FDA For Lucid-21-302, Its New Drug Candidate For Treatm

Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) (FRA: 0K91) ("Quantum BioPharma" or the &#34

12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com
Quantum BioPharma Enters Into Binding LOI With Allucent To Support Planned Phase 2 Clinical Trial Of

Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) (FRA: 0K91) ("Quantum BioPharma" or the &#34
benzinga.com
Quantum BioPharma Q4 EPS $(0.71) Beats $(0.93) Estimate

Quantum BioPharma (NASDAQ:QNTM) reported quarterly losses of $(0.71) per share which beat the analys

12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's Intraday Session
benzinga.com
Quantum BioPharma Publishes Data From Clinical Study Of NCT06505239 Of Its Dietary Supplement Produc

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) ("Quantum BioPharma" or the &#

12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
Reported On March 11: Quantum BioPharma Provides Corporate Update; Announces That Further To Its New

https://www.globenewswire.com/news-release/2026/03/11/3254229/0/en/Quantum-BioPharma-Provides-Corpor

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com
Quantum BioPharma Shareholder Sues Canadian Imperial Bank Of Commerce, Royal Bank Of Canada, RBC Cap

Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"),understands t

12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session

12 Health Care Stocks Moving In Wednesday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's Intraday Session

12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Tuesday's After-Market Session
benzinga.com
Quantum BioPharma To Broadcast Three-Part Series About Allegations Of Stock Market Manipulation Agai

Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) (FRA: 0K91) ("Quantum BioPharma"), is please
benzinga.com
Quantum BioPharma Q3 EPS $(1.25) Misses $(0.08) Estimate

Quantum BioPharma (NASDAQ:QNTM) reported quarterly losses of $(1.25) per share which missed the anal
benzinga.com
Quantum BioPharma Denies Unsubstantiated Securities Investigation Allegations, Vows Legal Action Aga

Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) (FRA: 0K91) (Upstream: QNTM) ("Quantum BioPharma
benzinga.com
Reported Earlier: Quantum Biopharma Reveals Cash Reward Of Up To $7M for Proof Of Market Manipulatio

TORONTO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) (FRA: 0K9
benzinga.com
Reported Earlier: Quantum BioPharma Sets Record Date Of October 27, 2025 For Litigation-Linked Conti

Quantum BioPharma Ltd.
benzinga.com
Quantum BioPharma Receives Two Key Final Reports Of Potential Breakthrough Drug For Multiple Scleros

Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) (FRA: 0K91) (Upstream: QNTM) ("Quantum BioPharma
benzinga.com
Quantum BioPharma Secures Health Canada Product License For Qlarity

Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) (FRA: 0K91) (Upstream: QNTM) ("Quantum BioPharma
benzinga.com
Quantum BioPharma Wins Buy Rating And $45 Forecast From Kingswood On Promise Of MS Drug Lucid-MS

Quantum BioPharma Ltd. (NASDAQ:QNTM) (CSE:QNTM) (FRA: 0K91) (Upstream: QNTM) ("Quantum BioPharma